Zimmer Biomet Holdings ZBH reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Zimmer Biomet Holdings beat estimated earnings by 10.3%, reporting an EPS of $1.82 versus an estimate of $1.65.
Revenue was down $244.90 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.2 which was followed by a 4.67% increase in the share price the next day.
Here's a look at Zimmer Biomet Holdings's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | 1.41 | 1.98 | 1.77 | 1.87 |
EPS Actual | 1.61 | 1.95 | 1.81 | 1.90 |
Revenue Estimate | 1.59B | 2.07B | 1.95B | 1.98B |
Revenue Actual | 1.66B | 2.04B | 1.92B | 2.03B |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
Zimmer Biomet Holdings management provided guidance for FY 2022, expecting earnings between $6.7 and $6.9 per share.
To track all earnings releases for Zimmer Biomet Holdings visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.